Efficacy and safety of erenumab in women with a history of menstrual migraine

BACKGROUND: We performed a post hoc, subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled study of erenumab for prevention of episodic migraine (STRIVE) to determine the efficacy and safety of erenumab in women with self-reported menstrual migraine. METHODS: Patients received...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Headache Pain
Hlavní autoři: Pavlovic, Jelena M., Paemeleire, Koen, Göbel, Hartmut, Bonner, Jo, Rapoport, Alan, Kagan, Risa, Zhang, Feng, Picard, Hernan, Mikol, Daniel D.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Milan 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398400/
https://ncbi.nlm.nih.gov/pubmed/32746775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-020-01167-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky